UNC Children's Hospital
Chapel Hill, North Carolina, 27614, United States
NCT Number: NCT01460329
The purpose of this study is to compare the accuracy and precision of two non-invasive methods of measuring cardiac output in critically ill children (<18 yrs). The participants will include any patient admitted to Pediatric intensive care unit (PICU) requiring a trans-thoracic ECHO (TTE) as part of their treatment plan. Measurements of intermittent cardiac output will be obtained and compared on participants using standard 2-D TTE and Ultrasound Cardiac Output Monitor (USCOM).
Looking for future studies?
Notify Me1 day–17 year
All sexes
Observational
Chapel Hill, North Carolina, 27614, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This device is FDA approved and based on the principles of ECHO using continuous-wave Doppler ultrasound to measure cardiac output.
Other names: USCOM
Time frame: measured at the time of study
University of North Carolina, Chapel Hill
Other
Comparing Cardiac Output Measurements in Critically Ill Children Using Ultrasonic Cardiac Output Monitor and Transthoracic Echocardiography.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06431802
Critical Illness, Disease Attributes
Shanghai, China
View Trial DetailsNCT04201704
Critical Illness, Disease Attributes
Buffalo, New York, United States
View Trial DetailsNCT06481644
Critical Illness, Disease Attributes
Singapore
View Trial DetailsNCT04612348
Critical Illness, Disease Attributes
Columbus, Ohio, United States
View Trial Details